Click to View Image
C22H29FO5 392.47

Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11,16)-.
9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione [50-02-2].
» Dexamethasone contains not less than 97.0 percent and not more than 102.0 percent of C22H29FO5, calculated on the dried basis.
Packaging and storage— Preserve in well-closed containers.
B: Ultraviolet Absorption 197U
Solution: 10 µg per mL.
Medium: methanol.
Absorptivities at 239 nm, calculated on the dried basis, do not differ by more than 3.0%.
Specific rotation 781S: between +72 and +80.
Test solution: 10 mg per mL, in dioxane.
Loss on drying 731 Dry it at 105 for 3 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.2% from 250 mg.
Chromatographic purity—
Formate buffer— Dissolve 1.32 g of ammonium formate in 1 L of water, adjust with formic acid to a pH of 3.6, and mix.
Mobile phase— Prepare a filtered and degassed mixture of Formate buffer and acetonitrile (67:33). Make adjustments if necessary (see System Suitability under Chromatography 621).
Test solution— Transfer about 180 mg of Dexamethasone, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with acetonitrile to volume, and mix. Transfer about 33 mL of this solution to a 100-mL volumetric flask, dilute with Formate buffer to volume, and mix.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L11. The flow rate is about 1 mL per minute. Chromatograph the Test solution, and record the peak responses as directed for Procedure: the column efficiency is not less than 5000 theoretical plates.
Procedure— Inject a volume (about 10 µL) of the Test solution into the chromatograph, record the chromatogram, and measure the peak responses. Calculate the percentage of each impurity in the portion of Dexamethasone taken by the formula:
100(ri / rs)
in which ri is the peak response for each impurity, and rs is the sum of the responses of all peaks: not more than 1.0% of any individual impurity is found, and not more than 2.0% of total impurities is found.
Mobile phase— Prepare a suitable degassed solution of water and acetonitrile (about 7:3) such that at an approximate flow rate of 2 mL per minute, the retention time of Dexamethasone is about 7 minutes.
Standard preparation— Prepare a solution of USP Dexamethasone RS in methanol having a known concentration of about 7.5 mg per mL. Dilute an accurately measured volume of this solution with the Mobile phase to obtain a Standard preparation having a known concentration of about 0.3 mg per mL.
Assay preparation— Using 30 mg of Dexamethasone, proceed as directed for Standard preparation.
Procedure— Introduce equal volumes (between 15 and 30 µL) of the Assay preparation and the Standard preparation into a high-pressure liquid chromatograph (see Chromatography 621) operated at room temperature by means of a suitable microsyringe or sampling valve, adjusting the operating parameters such that the peak obtained with the Standard preparation is 60% full-scale. Typically, the apparatus is fitted with a 4-mm × 25-cm column containing packing L7, is equipped with an UV detector capable of monitoring absorption at 254 nm and a suitable recorder, and is operated at about 1000 psi. Five replicate injections of the Standard preparation show a relative standard deviation of not more than 3.0%. Determine the peak responses, at equivalent retention times, obtained with the Assay preparation and the Standard preparation, and calculate the quantity, in mg, of C22H29FO5 in the portion of Dexamethasone taken by the formula:
100C(rU / rS)
in which C is the concentration, in mg per mL, of USP Dexamethasone RS in the Standard preparation, and rU and rS are the peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Daniel K. Bempong, Ph.D.
Senior Scientist
(MDPS05) Monograph Development-Pulmonary and Steroids
Reference Standards Lili Wang, Technical Services Scientist
USP32–NF27 Page 2083
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.